ArticleDatabase : the journal of biological databases and curation2026
STING-ExositeDB: An AI-assisted curated database of protein exosites for drug discovery.
Article in Database : the journal of biological databases and curation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationProtein exosites are secondary binding sites that recruit macromolecular partners and control molecular recognition across protein families. Despite their therapeutic potential demonstrated by approved drugs such as bivalirudin, systematic characterization remains limited by fragmented literature and inconsistent reporting. Existing databases lack exosite-specific curation, residue-level contact mapping, and structure-function integration.
resultsWe present ExositeDB, a curated database of protein exosites built through AI-assisted curation combining large language model extraction with expert validation. Our three-pass pipeline acquires papers from multiple databases, extracts data using GPT-4o with confidence scoring, validates findings against PDB structures, and links all claims to source text. The current release contains 525 expert-validated exosite records spanning 280 unique proteins, each annotated with residue-level positions, partner types, and functional roles. Quality is maintained through multi-tier confidence scoring integrating experimental methodology (35% weight), structural validation (25%), literature consistency (20%), and terminology precision (20%). The database follows FAIR principles through structured metadata, versioned releases, persistent identifiers, and an open REST API. Structural coverage includes 395 unique PDB structures supporting structure-function validation. ExositeDB provides training data for AI-driven exosite prediction, supports rational design of selective modulators, and enables analysis of exosite-mediated regulatory networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.